- Home
- ADTX vs ENVB Comparison
ADTX vs ENVB Comparison
Compare ADTX & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- ENVB
- Stock Information
- Founded
- ADTX 2017
- ENVB 1994
- Country
- ADTX United States
- ENVB United States
- Employees
- ADTX N/A
- ENVB N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- ADTX Health Care
- ENVB Health Care
- Exchange
- ADTX Nasdaq
- ENVB Nasdaq
- Market Cap
- ADTX 3.1M
- ENVB 3.1M
- IPO Year
- ADTX 2020
- ENVB N/A
- Fundamental
- Price
- ADTX $1.20
- ENVB $1.32
- Analyst Decision
- ADTX
- ENVB Strong Buy
- Analyst Count
- ADTX 0
- ENVB 1
- Target Price
- ADTX N/A
- ENVB $10.00
- AVG Volume (30 Days)
- ADTX 2.0M
- ENVB 154.2K
- Earning Date
- ADTX 08-18-2025
- ENVB 08-11-2025
- Dividend Yield
- ADTX N/A
- ENVB N/A
- EPS Growth
- ADTX N/A
- ENVB N/A
- EPS
- ADTX N/A
- ENVB N/A
- Revenue
- ADTX $55,323.00
- ENVB N/A
- Revenue This Year
- ADTX $15,768.94
- ENVB N/A
- Revenue Next Year
- ADTX N/A
- ENVB N/A
- P/E Ratio
- ADTX N/A
- ENVB N/A
- Revenue Growth
- ADTX N/A
- ENVB N/A
- 52 Week Low
- ADTX $1.05
- ENVB $1.01
- 52 Week High
- ADTX $21,400.00
- ENVB $11.55
- Technical
- Relative Strength Index (RSI)
- ADTX 39.51
- ENVB 52.44
- Support Level
- ADTX $1.13
- ENVB $1.18
- Resistance Level
- ADTX $1.30
- ENVB $1.37
- Average True Range (ATR)
- ADTX 0.11
- ENVB 0.06
- MACD
- ADTX 0.03
- ENVB 0.01
- Stochastic Oscillator
- ADTX 46.81
- ENVB 75.68
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.